Press Release Description

Proteomics Market to Thrive with the Prevalence of Infectious Diseases in Asia-Pacific

The Asia-Pacific Proteomics Market is projected to grow at a CAGR of around 7.8% during the forecast period of 2023-28, cites MarkNtel Advisors in the recent research report. The rising prevalence of chronic diseases, including cancer, arthritis, and chronic obstructive pulmonary disease, in APAC has driven pharmaceutical & biotech companies to intensify their research & development efforts for new drugs & therapies. With the onset of the COVID-19 pandemic in 2020, there was a quick boost in demand for testing kits, virology protein research, and vaccine development, leading to the promotion of proteomics solutions for their usefulness in large protein molecule testing of cells.

Moreover, various other non-communicable diseases, such as gastrointestinal, neurological, etc., have also enhanced among countries like China, India, etc., due to which the focus towards possible drug development with increased effectiveness has emerged. With the increased demand for drug development for non-communicable diseases, numerous new research & development institutes in the region have been established. For instance, in 2022, Kranikos Healthcare established its first oncology laboratory for comprehensive cancer diagnostic services.

Additionally, varied research & development institutes and organizations have announced their plans to expand their cancer research services in the region, which would be pivotal for the improved demand for proteomics services in the coming years. With the inclination towards drug development & providing timely testing services to patients suffering from chronic diseases, the demand for proteomics testing services is anticipated to grow in the coming years, further states the research report, “Asia-Pacific Proteomics Market Analysis, 2023.”

Asia-Pacific Proteomics Market

Asia-Pacific Proteomics Market Segmentation Analysis

Spectroscopy to Hold Significant Market with Increased Applicability in Drug Development

Based on the Technology, the market is bifurcated into Spectroscopy, Chromatography, Electrophoresis, Protein Microarray, Microarray Instruments, Crystallography, Surface Plasma Resonance, Fractionation, etc. Of these, Spectroscopy accounted for the majority share of the Asia-Pacific Proteomics Market. This prominence was attributed to several factors, like expanding applicability in identifying & studying molecules associated with various chronic diseases.

Spectroscopy solutions facilitated the analysis of charged species' masses by detecting & amplifying ions, allowing for anomaly detection & change identification. Owing to this, several companies like Thermo Fisher, among others, have introduced their dedicated spectrophotometer for proteomics study to cater to this incoming demand.

China to Hold Major Market Share in the Asia-Pacific Proteomics Market

China, with its huge healthcare budget as well as the availability of healthcare centers & medical research laboratories, held a prominent share in the Asia-Pacific Proteomics Market. Many new research & drug development facilities are anticipated to be established in the country, offering a major boom to the market due to its applicability in biomarker testing & drug effectiveness testing on subjects.

Moreover, continuous developments & investments have also been observed in the country, including enhanced investment in proteomics testing services & industry collaboration to advance proteomics solutions. Therefore, with the high investment in the healthcare sector & industry focus on building research & development infrastructure, China is anticipated to show rapid growth in the Asia-Pacific Proteomics Market during 2023-28.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danher Corporation, GE Healthcare, Thermofisher Scientific Inc., Merck KgaA, Promega Corporation, Bruker Corporation, Waters Corporation, MRM Proteomics Inc., Luminex Inc., Perkin Elmer Inc., are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

  1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
  2. What are the trends that have shaped the industry to its current form?
  3. What key factors would propel & impede the industry across the region?
  4. How has the industry been evolving in terms of geography & product adoption?
  5. How has the competition shaped across various countries, followed by their comparative factorial indexing?
  6. How have buying behavior, customer inclination, and expectations from product manufacturers evolved during 2018-28?
  7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?

Place an order
Only market data will be provided in the excel spreadsheet.

USD 3,100

The report will be delivered in PDF format without printing rights. It is advised for a single user.

USD 3,950

The report will be delivered in PDF format with printing rights. It is advised for up to five users.

USD 4,850

The report will be delivered in PDF format with printing rights and excel sheet. It is advised for companies where multiple users would like to access the report from multiple locations

USD 6,350

Need Assistance?


[email protected]
100% Safe & Secure

Strongest encryption on the website to make your purchase safe and secure